PNEUMOFOCUS

BULLETIN OF GAVI'S PNEUMOADIP AT JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH
PNEUMO ADIP: PNEUMOCOCCAL VACCINES ACCELERATED DEVELOPMENT AND INTRODUCTION PLAN


Volume 1, No. 11 December, 2004
EXECUTIVE DIRECTOR'S NOTE
2004 has been a year of preparation and momentum building: establishing surveillance networks, documenting leaders’ understanding of pneumococcal disease, and understanding vaccine demand and supply for developing countries. In the next 6 to 24 months we are expecting a lot of new information on pneumococcal disease and its prevention. New disease burden data from countries and the WHO, cost-effectiveness analyses and more are expected in the first half of 2005 alone.

In this issue of pneumoFOCUS you’ll read about the upcoming WHO-sponsored PneumoADIP investigators’ meeting in Dhaka, Bangladesh and a recent WHO regional conference working to establish pneumococcal disease surveillance in the Eastern Mediterranean Region. We’re asking you to send us your “wish list” for important unpublished data that deserves to appear in a peer-reviewed journal but whose authors have never found the time to write the manuscript. We at PneumoADIP wish all of you and your families a very happy holiday!



Orin Levine
Executive Director
SMALL GRANTS PROGRAM - 1 FUNDING CYCLE REMAINING

PneumoADIP’s final Small Grants deadline is February 15, 2005. Please remember that this is the very last cycle of Small Grants funding. For more information about the program and how to apply visit us online at www.preventpneumo.org

BBC WORLD ZOOMS IN ON PNEUMOCOCCAL DISEASE

GAVI’s PneumoADIP is pleased to sponsor an episode of the upcoming BBC World documentary series, “Kill or Cure.” This particular episode will focus on pneumococcal disease in developing countries, giving a human face to those suffering from it and looking at what is being done to prevent it. Filming took place in October in Soweto, South Africa and in Kilifi, Kenya with cooperation from Drs. Shabir Madhi and Keith Klugman in Soweto and Drs. Anthony Scott, Mike English and Wamae Maranga as well as Ms. Beverly Watila of NetSPEAR in East Africa. The first episode of the series will air on January 6, 2005. Please stay tuned for more information on this exciting project and click here to see BBC World’s description of the program.

CALL FOR "MOST IMPORTANT UNPUBLISHED DATA"

Do you consistently reference or use important data in your work that has gone unpublished because no one has gotten around to writing up the manuscript and submitting it to a journal? PneumoADIP is requesting suggestions of work that you believe is very valuable but has, for whatever reason, remained unpublished. We will supply resources to move that work towards journal submission so that others may have access to the results.

Please email suggestions with contact information to hparsons@jhsph.edu

EMRO INTER-COUNTRY WORKSHOP ON PNEUMOCOCCAL DISEASE SURVEILLANCE

Cairo, Egypt, December 7-8, 2004 – In order to develop recommendations for a regional pneumococcal disease surveillance network the WHO’s Eastern Mediterranean Region held a meeting here bringing together leaders in vaccines and research from throughout the region. Participants included EPI managers, the International Pediatric Association, the Naval Medical Research Unit 3 (NAMRU-3), universities, Centers for Disease Control, Glaxo Smith Kline, Sanofi-Aventis, WHO Headquarters and PneumoADIP, all of whom recognized the need for surveillance in the region.

Participants left the meeting convinced of the need for situation analyses regarding data collection in each country, and excited to return for the first regional pneumococcal disease surveillance workshop in summer 2005. WHO HQ and PneumoADIP agreed to provide technical assistance to the countries as they work to establish and improve disease surveillance.

TRAVEL GRANTS PROGRAM: EIGHTH ANNUAL CONFERENCE ON VACCINE RESEARCH

The Eighth Annual Conference on Vaccine Research will be held May 9 – 11, 2005, in Baltimore, Maryland. The largest scientific conference devoted exclusively to vaccinology, it features both submitted abstracts and invited presentations across many disciplines to encourage the exchange of ideas and approaches for immunization against diverse human and veterinary pathogens and conditions. The conference is cosponsored by the National Foundation for Infectious Diseases (NFID), and 11 other national and international agencies, institutes, and organizations.

A new travel grants program, sponsored by the Bill and Melinda Gates Foundation, offers financial support to researchers in resource-limited countries to present their work at the conference. Deadline for submission of application and associated abstracts for travel grants is January 3, 2005.

Conference attendees can register online now. Deadline for online submission of abstracts for oral and poster presentations is February 7, 2005. Program announcements and information on abstract submission, registration, hotel reservation, and travel grant application are available at http://www.nfid.org/conferences/vaccine05; from NFID, Suite 750, 4733 Bethesda Avenue, Bethesda, MD 20814-5278; telephone 301-656-0003, ext. 19; fax 301-907-0878; or e-mail vaccine@nfid.org.

WHO/IVB TO SPONSOR PNEUMOADIP INVESTIGATORS' MEETING

Dhaka, Bangladesh, January 17-18, 2005 – The World Health Organization’s Immunizations, Vaccines and Biologicals division will sponsor the second PneumoADIP Investigators’ Meeting: Surveillance of Laboratory-Confirmed Pneumococcal Disease here at the BRAC Center. The meeting will bring together pneumococcal disease surveillance investigators supported by PneumoADIP in order to build support between networks and to share best practices. Meeting participants will review progress in each surveillance network since September 2003 and will assess the comparability of data collected by different networks. They will discuss future directions for networks and collaborators. PneumoADIP is looking forward to this time for its investigators to reflect on all that they have accomplished so far and on the future direction of the networks.

GAVI TO REQUEST PROPOSALS FOR HIB TEAM

Recognizing the challenges developing countries are facing in making decisions about whether to introduce Haemophilus influenzae Type b (Hib) vaccination and how to maintain it once it has been introduced, the Board of the Global Alliance for Vaccines and Immunization have decided to create and support a team dedicated to filling the information gaps. The team would somewhat resemble an ADIP, but for an already available vaccine. Early in 2005 the GAVI Board will issue a request for proposals to establish this team; a funding ceiling of $37 million over 4 to 5 years has been decided.